GEN Exclusives

More »

GEN News Highlights

Back to Item »

HistoRx Licenses Yale University’s Prognostic Biomarker Assay for Melanoma

Test based on AQUA technology will help predict node-negative patients who are most likely to develop disease recurrence.

Forward this item to a colleague:


 
   

(Separate multiple addresses by commas)

   

(Separate multiple addresses by commas)

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Alzheimer's Therapies

Do you think an effective treatment for Alzheimer’s will be found within the next 10–15 years?